FRA1 drives melanoma metastasis through an actionable transcriptional network
8.0
来源：
Nature
关键字：
multi-omics
发布时间：
2025-11-25 08:07
摘要：
FRA1 is identified as a key driver of melanoma metastasis, enhancing the ability of melanoma cells to colonize and grow in distant organs. The study reveals a transcriptional network controlled by FRA1 that includes AXL, CDK6, and FSCN1, which are associated with poor patient outcomes. Targeting these pathways may provide new therapeutic strategies for treating metastatic melanoma.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+1.0
business_impact
1.0分+1.0
scientific_rigor
1.5分+1.5
timeliness_innovation
1.5分+1.5
investment_perspective
2.5分+2.5
market_value_relevance
1.0分+1.0
team_institution_background
0.5分+0.5
technical_barrier_competition
1.0分+1.0
关键证据
FRA1 enhances both the initial seeding and subsequent outgrowth of metastatic lesions.
Pharmacological inhibition of CDK6 and FSCN1 suppressed melanoma metastasis.
The expression of FRA1 correlates with poor patient outcomes across multiple cancer types.
真实性检查
否
AI评分总结
FRA1 is identified as a key driver of melanoma metastasis, enhancing the ability of melanoma cells to colonize and grow in distant organs. The study reveals a transcriptional network controlled by FRA1 that includes AXL, CDK6, and FSCN1, which are associated with poor patient outcomes. Targeting these pathways may provide new therapeutic strategies for treating metastatic melanoma.